Top 5 Most-Read Heart Failure Content of 2025

Our top 5 heart failure articles of 2025 include FDA approvals, improving guideline-directed medical therapy (GDMT), markers of progressive heart failure (HF) such as findings from echocardiogram screenings or social determinants of health, and value-based care models for patients with heart failure.

Here are the top 5 pieces of content for heart failure, and click here to see all our coverage.

5. What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD

On this episode of Managed Care Cast, The American Journal of Managed Care^® spoke with Ty Gluckman, MD, a practicing cardiologist at Providence Heart Institute in Portland, Oregon, about strategies to improve guideline-directed medical therapy (GDMT) implementation. The discussion encompassed his panel at the Institute for Value-Based Medicine (IVBM) on the underuse of GDMT in heart failure (HF) and opportunities for remote patient monitoring and digital health tools to support optimal therapy for patients with heart failure.

Listen to the full episode.

4. Left Bundle Branch Block May Be Key Indicator of Progressive Heart Failure

Left bundle branch block (LBBB) detected on an electrocardiogram may signal progressive worsening in patients with HF, potentially helping physicians identify those at higher risk of adverse outcomes. The study findings associate LBBB with structural and functional changes, suggesting it could be a useful marker for clinicians to help improve early recognition that could help physicians personalize treatment and improve patient management.

Read the full article.

3. FDA Approves Finerenone for Heart Failure with Mildly Reduced or Preserved LVEF

The FDA approved finerenone to treat patients with HF with left ventricular ejection fraction (LVEF) based on findings from the 3 FINEARTS-HF trials that demonstrated a statistically significant reduction in the composite end point of cardiovascular death and total heart failure events. Scott D. Solomon, MD, professor of medicine at Harvard Medical School, said the clinical efficacy demonstrated in the trial has the potential to become “a new pillar of comprehensive care.”

Read the full article.

2. Social Determinants of Health Linked to Congestive Heart Failure Deaths

Social determinants of health (SDOH) combined with congestive heart failure were found to be associated with a higher mortality rate, as SDOH hinder patients’ ability to adhere to and obtain consistent care for complex heart failure management. The research authors emphasize the need to address nonmedical factors for improving heart failure outcomes and reducing health disparities across populations, encouraging health systems and policymakers to integrate social risk screening and targeted interventions to better support underserved patients.

Read the full article.

1. Value-Based Care Is Key to Bringing Cardiology Breakthroughs to Those Who Will Benefit Most

Value-based care models are essential for ensuring patients who could benefit most from cardiology breakthroughs actually receive them, particularly as innovation accelerates in cardiovascular medicine. The article highlights how aligning financial incentives with outcomes, rather than volume of services, can improve access to advanced therapies, reduce disparities, and enhance long-term patient outcomes. Systems that adopt value-based strategies are better positioned to deliver equitable, cost-effective cardiovascular care.

Read the full article.